PPD Inc logo

PPD - PPD Inc Share Price

$46.1 -0.1  -0.1%

Last Trade - 07/05/21

Large Cap
Market Cap £11.58bn
Enterprise Value £14.11bn
Revenue £3.35bn
Position in Universe 703rd / 6858
Unlock PPD Revenue
Relative Strength (%)
1m +18.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.84%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 2,680 3,001 3,749 4,031 4,681 5,490 5,958 +15.0%
+47.2 -58.0 -55.8 +248.6 +149.1 +14.6
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, PPD Increvenues increased 16% to $4.68B. Net income applicable tocommon stockholders increased from $54.7M to $120.2M.Revenues reflect Clinical Development Services segmentincrease of 50% to $3.8B, Laboratory Services segmentincrease of 46% to $876.6M, North America segment increaseof 23% to $2.65B, Asia Pacific segment increase of 22% to$508.9M, Europe.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


PPD Revenue Unlock PPD Revenue

Net Income

PPD Net Income Unlock PPD Revenue

Normalised EPS

PPD Normalised EPS Unlock PPD Revenue

PE Ratio Range

PPD PE Ratio Range Unlock PPD Revenue

Dividend Yield Range

PPD Dividend Yield Range Unlock PPD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PPD EPS Forecasts Unlock PPD Revenue
Profile Summary

PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services offerings span the lifecycle of clinical product development and includes product development and consulting services, early development services, phases II-IV clinical trial management, accelerated enrollment solutions, peri- and post-approval services and medical communications. The Company’s Laboratory Services segment offers bioanalytical laboratory services, biomarker laboratory services, vaccine science services, good manufacturing practice (GMP) laboratory services and central laboratory services.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
No. of Shareholders: 60
No. of Employees: 26,000
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 350,976,576
Free Float (0.0%)
Eligible for
PPD Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PPD
Upcoming Events for PPD
Monday 2nd August, 2021 Estimate
Q2 2021 PPD Inc Earnings Release
Monday 25th October, 2021 Estimate
Q3 2021 PPD Inc Earnings Release
Frequently Asked Questions for PPD Inc
What is the PPD Inc share price?

As of 07/05/21, shares in PPD Inc are trading at $46.1, giving the company a market capitalisation of £11.58bn. This share price information is delayed by 15 minutes.

How has the PPD Inc share price performed this year?

Shares in PPD Inc are currently trading at $46.1 and the price has moved by 74.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PPD Inc price has moved by 21.35% over the past year.

What are the analyst and broker recommendations for PPD Inc?

There are no analysts currently covering PPD Inc.

When will PPD Inc next release its financial results?

PPD Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the PPD Inc dividend yield?

PPD Inc does not currently pay a dividend.

Does PPD Inc pay a dividend?

PPD Inc does not currently pay a dividend.

When does PPD Inc next pay dividends?

PPD Inc does not currently pay a dividend.

How do I buy PPD Inc shares?

To buy shares in PPD Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of PPD Inc?

Shares in PPD Inc are currently trading at $46.1, giving the company a market capitalisation of £11.58bn.

Where are PPD Inc shares listed? Where are PPD Inc shares listed?

Here are the trading details for PPD Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: PPD
What kind of share is PPD Inc?

Based on an overall assessment of its quality, value and momentum, PPD Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a PPD Inc share price forecast 2021?

Shares in PPD Inc are currently priced at $46.1. At that level they are trading at 2.54% discount to the analyst consensus target price of 0.00.

Analysts covering PPD Inc currently have a consensus Earnings Per Share (EPS) forecast of 1.477 for the next financial year.

How can I tell whether the PPD Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PPD Inc. Over the past six months, the relative strength of its shares against the market has been 8.69%. At the current price of $46.1, shares in PPD Inc are trading at 28.88% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the PPD Inc PE Ratio?

The PPD Inc PE ratio based on its reported earnings over the past 12 months is 77.74. The shares are currently trading at $46.1.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of PPD Inc?

PPD Inc's management team is headed by:

David Simmons - CHM
William Sharbaugh - COO
Christopher Scully - CFO
Anshul Thakral - EVP
B. Judd Hartman - EVP
Christopher Fikry - EVP
Ronald Garrow - CHO
David Johnston - EVP
Karen Kaucic - EVP
Joe Bress - IND
Stephen Ensley - IND
Maria Hilado - IND
Colin Hill - IND
Jeffrey Kindler - IND
Julia James - EVP
Who are the major shareholders of PPD Inc?

Here are the top five shareholders of PPD Inc based on the size of their shareholding:

H&F Globe Investor LP Corporation
Percentage owned: 21.97% (77.1m shares)
The Carlyle Group Private Equity
Percentage owned: 15.88% (55.7m shares)
H&F Corporate Investors VIII Ltd Investment Advisor
Percentage owned: 15.88% (55.7m shares)
GIC Private Limited Sovereign Wealth Fund
Percentage owned: 6.14% (21.6m shares)
Abu Dhabi Investment Authority Sovereign Wealth Fund
Percentage owned: 6.12% (21.5m shares)
Similar to PPD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.